The Green Room Podcast

Ep 54 - Jumping into the Cannabis industry. An interview w/ Adam Bushey, Director of Strategic Growth at Open Book Extracts

January 25, 2022 Ronjini Joshua, Adam Bushey Episode 54
The Green Room Podcast
Ep 54 - Jumping into the Cannabis industry. An interview w/ Adam Bushey, Director of Strategic Growth at Open Book Extracts
Show Notes Transcript

After 15 years in the medical field working on both the human & veterinary sides, Adam Bushey made the jump into the Cannabis/CBD industry.  He is the director of strategic growth at Open Book Extracts.  

Open book Extracts - bringing scientific rigor to every ingredient they sell and formulate, from traditional medicine, to modern nutrition science, to clinical program design, and translate their data into messages you can use.

What sets Open Book Extracts apart from others is they also deal in rare cannabinoids such as TCV. Along with other rare cannabinoids - cbdv, CBDa, CBGa, THCV. Adam said there's so many exciting variables or exciting cannabinoids coming out very soon.  Listen to this episode to learn more about the extracts being researched by the team of experts at Open Book Extracts. 


Connect with Adam:

https://www.linkedin.com/in/adam-bushey-49aa718b/

https://openbookextracts.com/team/

https://www.instagram.com/obxtracts/


Remember to subscribe to be notified of our next episode.  Please like & Share!  Check out our website for all of your Cannabis PR Solutions. 

Ronjini Joshua:

In this next interview, we took a little bit more of a scientific approach. And speaking with Adam Bushi, from open book extracts, he talks about his journey of how he got into cannabis. And furthermore, his journey of how he got into extraction and what cool things. They're doing an open book based in California. So let's jump into the interview now. Hello, we are back today with Adam. But she from open book extracts. Thank you for joining me, you are the Director of Strategic Growth. Yes, yes. So you guys are here. Are you guys exhibiting here mjbizcon. This week,

Adam Bushey:

this week, we're not we're exhibiting next week for another trade show. But this week, we just kind of wanted to, you know, the first big one back, we wanted to walk the floor meet with a bunch of clients. And so

Ronjini Joshua:

to that vein, you know, what was the biggest anticipation coming here to Vegas?

Adam Bushey:

I think it was more of a, wondering how it's going to be, you know, it's going to be like we we've entered into cosmic Prov and a couple of the other semi cannabis, trade shows, and some of them were devastated, you know, third of the attendees. So it's like a unknown factor right now, are we going to show up and it's booming, like, MJ is this year? Yeah. Phenomenal, are very excited, or is it going to be normal? Or is it going to be less? I mean, there's nobody knows, what do you know is it's already sad. And every show will tell you, Oh, we're at capacity, or we sold this many, but they want people to come right. And you don't know what's true and what's not. And it was true with MJ. It's amazing. You know, they stacked it, the energy is amazing. Everybody's happy to be back in cannabis and be mingling and talking. And I mean, it's just, it's nothing like it. So we're very happy to be back and very excited to be at a show this this size. Yeah. Hopefully that continues forward to next year, everybody gets their energy back. And they're all coming in. And we can have a lot of great conversations.

Ronjini Joshua:

So what were you personally looking forward to the most?

Adam Bushey:

I love, like, face to face interaction, that's my biggest thing, sales tactic that I exceed that. So you know, for the last two years, it's been a lot of virtual, a lot of phone calls a lot. I mean, it's just, you know, and it's fine, it's safe, and it is what it is, but I missed the old days of being in person closing a big deal in person, taking people out to dinner, get to know their family and talking about different things. And, you know, we missed that for a while. And we had some interaction with clients, but it was very sparse. And now it's like that we're just walking the floor, having engaging conversations, talking about this crazy thing that they're doing or your thing and how we can come together. And those conversations and face to face are so much more beneficial. I think for you know, our company growth versus, you know, cold calling and all the other things we've had to do for a couple years.

Ronjini Joshua:

Yeah, at the end of the day, we're all people. So I think that interaction is really important. You had mentioned like, you're you've been de MJ about four times, four times. So tell me like, What do you think from the first time you've come to today? And obviously, like, so much has happened? But what do you see is the biggest things.

Adam Bushey:

It's interesting is it's like, there's so many new type of companies here that I've seen before, right? So it's like, it's not just hemp in cannabis brands anymore, and just people getting started. Now, it's established brands, it's industrial equipment, it's water purification. I mean, there's so there's securities, there's, you know, like the gentleman had earlier, all those types of things now that I didn't really see before it was kind of just like a startup kind of shop of like, rough and tumble cannabis and a lot of good old OG vibe kind of thing. Yeah, now, it's like, there's a lot of corporate mixing, there's a lot of still the OG and the more older vibe. And then there's also like entrepreneurs, and essentially, a collective group of people that I've never seen before at one trade show. A lot of interesting boosts colors changes, the techniques. You know, it's definitely the most comprehensive show in this area I've ever been to where you can just find anything you need, you know, right off the bottom, whether you're doing, you know, manufacturing, or you're doing sourcing, or you're farming or whatever it is, it's pretty crazy.

Ronjini Joshua:

Yeah, I mean, it's it's kind of a testament to a growing industry, how it's like just expanding into every area of the business. So now it's like a has equal representation and all these different areas,

Adam Bushey:

right. And instead of having to go to a manufacturing Expo, right, for growing Expo, or whatever, you can come to MJ Yeah, and get everything. And I mean, it's a long day to walk through that. You can learn a lot you can see a lot and I mean, any questions you have, I mean, we were just talking on yesterday, you could literally walk in as an entrepreneur with just a plan. You could have enough interaction in that in mg to start your own business, get everything figured out and have a product lead time you walk out the door. Yeah, it's

Ronjini Joshua:

pretty amazing. Well, that is the good news. Good news that like the growth is kind of really happening now. But this is a really exciting time I think in the cannabis industry. And we'll love to talk to about about you, and how did you What was your journey getting into cannabis personally, and then we'll talk a little bit about open book extracts and kind of what their journey has been and where you guys are going.

Adam Bushey:

Yeah, so had a funny journey. I've been in the medical field prior for 15 years and on the urology space on the human side and on the veterinary space on the animal health side, okay, and sold equipment worked with veterinarians worked with urologists and other surgeons and things. And through the last, like five years of that relationship with that company, a lot of trade shows I went to, especially in the veterinary side, sort of having booming booths everywhere with CBD and cannabis related, okay, and then it will childhood friend, his name's Steven cytol, he traveled the country. And he's a RVT in the veterinary space, he traveled the country speaking about the benefits of cannabis in the animal health side and how it can really help with lots of different issues. And he was kind of a pioneer along with another gentleman named Robert silver. So they kind of they wrote a book together and they did a lot of these tours and getting to know him again, reconnect with him after after high school, to learn about all those possibilities and the exciting things that you can do that don't involve, you know, chemical components and everything else. It's very interesting. I no idea about cannabis or hemp at all. And then it was just a random luck streak that one of my best friends joined folium Biosciences over in Colorado, and we were at a bachelor party, and he's like, how's your job going? I'm like, I love it. It's great. He's like, I gotta tell you about CBD and hemp he's like, it's it's a crazy market is exploding. This was back in early 2019, when I ended up taking the position. And it was like at the peak, you know, of all these big attraction companies raising to ramp up. And so I went ahead to interview through nothing about cannabis or hemp, you know, barely anything that I learned at the veterinary show, and I was about it. And it just found a good fit that it was exciting, the you know, the sky's the limit on you know, the product and everything else. And then I just start learning about it and learning the effects and the benefits for helping people with opioid addiction. All the other beautiful things that it helps with, and had a little bit of a rocky go at folium ended up leaving. And then I found a manufacturer in San Bernardino near where you're at. And they were doing custom formulations for cannabis CBD related products. And it was awesome, because I get to come in and start a sales team with them, build out reps and manage the team. You know, we grew 700% In the first year. And we enjoyed a lot of success. And it was just a beautiful situation because we got to create these products specialized for different people to be unique to have certain cannabinoid molecules or supplements that ated the cannabinoids to make a lotion, or gummy or whatever else to really help and be a good efficacy for the problem or the fix that they were trying to have. And then one of my biggest clients became oak extracts. So I've sort of worked with them intimately about a year ago and visited the facility and met the whole team and two of my best friends joined their team as well. And just through those interactions, it was just like a perfect match. And so I just decided, actually a month ago to join their team that left the manufacturing side to go back to the extraction side and you know, couldn't be happier. I get to have my hands and everything help the team with different parts of growth and trying to bring it we have a big goal to hit for lots of different things you want to do this next year. Yeah. And you know, it was exciting to be able to go back in but to a company that really believe in and trust. And you know, there was a lot of there's a good amount of companies extracting right now. But the reason that you know I made that decision to go there was because I see the long term potential with their focus. And their focus is on rare cannabinoids and those specific unique, you know, form factors. So going forward, CBD is great. CBG is great. You know, they have they have great purposes. But at a certain point, we all need to get unique. We all need to get specialized, we need to find out what is your problem that you're you want to deal with? And how do we fix that? Just by blanket saying take CBD, it'll fix everything. We go, No, we have a custom formulation with five different molecules and different variations to really target that issue, whether it's anxiety or sleep or depression, whatever it is. There's we've been involved with studies over at a few colleges near North Carolina, where we're at doing actual research to show this is efficacious, and this does this and this helps with this. And after we build that out, we're going to be able to have different offerings. And that's the biggest difference with open book is the custom oil that they're able to create to really specify what the issue is, how do we fix it? How do we resolve it? How do we create a new unique product that's gonna last in the market? And I think in the next year, maybe two years, it's really going to move that direction. And so the company is pumping out CBD isolate those kinds of things. Okay, they're going to have to figure out And you know how to work with these other molecules, because everybody's gonna want to have something that really works. And it's not just for the sake of taking, you know, CBD, something like that.

Ronjini Joshua:

Right? So so how does it how do you guys work at Open Book extracts? Like how do you guys work with brands and products to get those products developed? I mean, you kind of gave a quick overview on that, but like, really like how does it work to kind of identify? How do you how do you identify what molecules do what and how to, like, you know, optimize those for for like you said, you didn't say eczema, but I'm just putting out eczema out there, anxiety, stress, sleep, whatever, whatever the case is, right? So,

Adam Bushey:

I mean, we have 10 PhDs on staff that do different things, from r&d, to manufacturing, to formulation to everything else. We brought in a whole team from the nutraceutical supplemental side. Cool. We have a team from the the like skincare side, and then we have obviously beautiful minds in the cannabis side. So together, you know, we know what supplements will work best in this formulation, whether it's a you know, an edible item, or in the topical side, you know, what ingredient will help with eczema or something else? No, it's good. It's a good example, because you can pick a cannabinoid that might help with that skin condition. But there's also so many other great supplements that already do that we know and they're verified for hundreds of years. Right? Right. So we can combine those and get the best efficacious product out of it without having to just say, No, you're fine. With just cannabinoids, our team is so developed that we can create these core new products that are unique that in that involve all those different aspects of supplements, nutraceuticals, and everything else. So now you have this top line skincare product that you find. But now you can infuse it with cannabinoids that actually target that issue as well. So those r&d teams work together to figure out a final solution to get that product the way it should be, and to be efficacious for the user. And then we're able to basically scale that, you know, from a small mo Q order up to you know, millions of units, depending on the size, and we have different relationships with, you know, finished good manufacturers to build those out after we do the r&d work and really get a formula that works for them.

Ben Michaels:

When you get these, you know, formulas together, like how much because like I know, like, like CBD can like work well, you know, alone, and I personally tried some CBG pills that were like absolutely amazing. But like how much does like the entourage effect come into play when you're isolating some of these other lesser known ones that come in and speak treat the more specific parts?

Adam Bushey:

It's a good question. And I mean, Entourage is always like an amazing feature for kind of targeting a lot of issues at once and overall health, you know, the endocannabinoid system, getting every go your reactors and everything. But it, I think it depends on the issue you're trying to fix. Because if you have a specific issue that you can target, using something that's like a full spectrum that has a lot of the miners mixed in, it has a lot of the fatty acids, the flavonoids, all the different components that make up a really rich oil, which are great, but you might not have enough CBG or CBN, to target that issue that you have. And so we can still include and that's what that's what is different about openbook is that you can we can create these custom distillates and custom isolates together that have a profile specific for that need, that had and it can continue the entourage idea because we didn't reintroduce terpenes anything else that's necessary for that final goal. But I think that's where the future is. It's not just about taking something with entourage and helping 20 different issues. It's if you wake up in the morning, you have back pain, how can we target that if the next morning you have stress? Or you have anxiety? How can we target that. So thinking the same thing and kind of helping with everything, we can target something and try and hit it at the core. And then the next day you have some a different problem, we have a different product for that. And we can you know target those as well. But it is overall if you're just taking as a daily supplement the like nothing better than having the full entourage you just bring everything and pump everything. But if you're targeting an issue and you want to resolve that issue, that's where this comes in to be able to break out that formula. That's awesome.

Ronjini Joshua:

So you have a pretty sophisticated team. I mean, like that's a lot of people. So do you guys specialize and we talked about skincare we talked about edibles? Is there an area where you guys specialize particularly

Adam Bushey:

we specialize in the rare cannabinoid extraction. Rare cannabinoids Yeah, so we so and we we also obviously produce CBD broad spectrum, full spectrum, isolate all that Standard Oil content, but we specialized in the rare cannabinoids, like thc v is a really interesting new cannabinoid. We're the world's largest extractor and provider of that currently, and that's like an energy kind of cannabinoid. It's not there's no hallucinogenic, partial to it. It's a very like mild kind of energy effects from it, but it's very exciting molecule right now. It's expensive to extract so we're working on getting that down so it'd be a little more affordable so more people can get into their daily regimen, but things like that, like we you know, we

Ronjini Joshua:

do Would that be in like an edible type format then can be

Adam Bushey:

in it? Yeah. Mainly edible. Yeah. You know, oral drop gummies chocolate event, something like that. On the skin here. I don't actually know it's an interesting question that ended dive into I don't know what effects it has on skin. Yeah, but I know its main effects are like, similar to a cup of coffee or energy drink. And then mental, like, clarity, clarity. Exactly, yeah, yeah. And so you know, there's over 100 cannabinoids in the plant. Yeah, and we our goal is to find each of the new interesting cannabinoids that so fall in the in the hemp bill in the in the 2018 Hemp bill. So is it staying away from the THC side, but finding all these cannabinoids that we can extract legally? And what are the use for them? Where can we target this? How do we make a better product for our clients and be the first ones out the gate to offer everything. And that's the end goal is to be like a one stop shop for every product, every cannabinoid, you come to us, we can build you something from nothing with just an idea. We can put in our own input and kind of consult on it and say, This is great, this is great, you know, stay away from this or here's a milligram you need for this to be efficacious. Those kinds of things we can help with that we they come in with an idea and they want to get this brand going or they want a new project to run. We can come in and just help the entire process along and we're not having to park stuff out or you know, source things from other places. We can do it all in house.

Ronjini Joshua:

So what is the question? So I'm uh, I mean, I don't know why keep using skincare. I'm a skincare brand, okay? And let's say I'm Neutrogena, whatever. Yeah, I'm coming to you. And I say, hey, look, we really want a product that addresses ekzema. But you know, it like what is the next step to that? Well, is that is that the kind of is that the way the brands will work with you? Or is it a different kind of way?

Adam Bushey:

No, there's so there's like three ways that that conversation starts. Yeah, way is they walk in the door, they're brand new, they just excited want to get a company rolling, and they want to be involved in cannabinoids, and they have a passion and skincare. Yeah, we'll do a lot of consulting, we'll bring in some people to consult on maybe what types of bases they should use, you know, lotion versus SAV, like a ball, you know, different aspects for what they're trying to achieve. We'll figure out the other added ingredients, nutraceutical ingredients that can help along with the cannabinoids, find a camp cannabinoid profile that works for that. Yeah, the application. And that's a little more rigorous, but you know, it's dealing with a new client. And that's, that's our goal is to help everybody go start at the bottom and be, you know, up in the big stores as soon as they can. The second relationship is they come in and they're like, Okay, here's what we want. We have a little guidance here. Here's what we're looking for. Can we do it? And then we'll look at the list of ingredients, figure out which ones work together, which ones might be counteractive and, you know, have an issue with stability or whatever else. We can do r&d with it to make sure it's a stable product. And then we finish that product out and then they're ready to launch. The third way is people come in they go, I love this product. Here it is, I want to recreate it but I cannabinoids, you know, can you do that. And then what we'll do is we'll take that product, we'll look at the ingredients, we'll you know, backwards. Get down, figure out how to replicate that. But make it better simpler if we can and add the cannabinoids in and then get to that product. So normally, it's one of those three, even if it's not skincare, it's one of those three on everything, to have one of those entry level points. And then we have ways with our team how how we're built out, it's it's unbelievable. But we have people in place to do all three of those and help them succeed no matter, you know what way they're entering the market.

Ronjini Joshua:

So the people that are formulating the base of whatever you're making is like a whole different team than the people that are incorporating the cannabinoids Right? Or no,

Adam Bushey:

they're gonna do the blending. But there's a different team that extracts cannabis. Yeah, testing and everything else. And so yeah, there's teams that do the different levels, but r&d Altogether, that all the all other minds come together. Yeah, they work in their different aspects of, let's introduce this, let's try this. And then they work together to get that final product out.

Ronjini Joshua:

So scalability is it sounds like is one of your kind of key things to being able to scale up. So what kind of brands I mean, you're obviously working with bigger brands is this kind of like the overall like, you know, corporate consumer size brand that that's really coming to you guys for this formulation.

Adam Bushey:

It's it's such a broad market. I mean, there are large corporations we're working with, we're under NDA, because we can't unfortunately talk about them, but they're but they're the big beverage, big MSOs, like, lots of different corporations that we're working with on that scale, mainly providing just wrong reading to them, because they already have manufacturing setup there. Okay, they're rolling that way. Then we have the medium sized clients that are doing large volume across multi states, but you know, they needed a little help with r&d or formulation or manufacturing. And when you take on those clients, and then we have a lot of entry level clients that are in a space already, and they're jumping into cannabinoids, or they're new to this space altogether, and then they're starting a brand from nothing. So we have we have all three of those interactions on a normal basis. And we have applications or options for all three in order to start small or scale right away or back and forth, depending on the need for the product.

Ronjini Joshua:

So you guys are focusing in this rare extraction. Like what, like I guess you're never gonna get all of them I guess at the end of the day, you We still have more to explore. But you said you're you guys were mentioning you were mentioning kind of focusing in city CBD space right now. Are you going to be moving to the THC THC and getting those connect cannabinoids as well

Adam Bushey:

so our founders have a background in THC that's where they started. Okay okay in them in the market and I think they're definitely they're waiting probably for legalization. Yeah, okay, negotiation happens. I think that skill level they already have. Yeah, silly not to do everything. Especially it's going to be kind of under the same umbrella. I think once THC is legalized? Yeah, I've been TCU primary together. So in one cannabis, you know, market? So I think yeah, absolutely. We'll be in that right now. We know we can dabble in what we can, and in order to reach all 50 states. But you know, when that finally opens up, and we're also hopeful for that, yeah, I think we're gonna be ready to rock on THC side as well.

Ronjini Joshua:

I mean, there's so many exciting companies that are doing similar things, like how do you really identify the kind of company you want to work with, especially when it comes to extraction? Obviously, you guys kind of carved out a niche, which is smart and very nice. But you know, if someone says, oh, well, I don't need a rare cannabinoid, I just, you know, I'm just looking for a run of the mill, like, what, what is like, what is kind of the decision making factor between leveraging open Buck extracts versus another extraction company? Or is it not for everybody? Or, you know, how does that work?

Adam Bushey:

It's right now with the way the market is fluctuated, it's a lot of price comparison. Okay, yeah, we're very price competitive, we don't normally lose those battles, unless it's a rare occasion. But outside of that, it's more about relationship building, right. So like a lot of our staff, our sales staff, including myself, we have these relationships we've had for three or four years. And at the end of the day, if especially in the cannabis world, we're all we all love each other, we all want to be part of this, you know, forever for the long run, is if I know you and trust you, and you can you can be competitive with pricing. I'd rather just work with you and not to keep changing things and have somebody reformulate something or get a product or have to

Ronjini Joshua:

recreate it again or like, Yeah, you don't start from scratch. Yeah,

Adam Bushey:

yeah. And so it's a lot about relationship building. This is why I love being MJ I love finally being back in front of people and talking to people, because you start that relationship early. And then you know, we'll figure out a way to get it done for them and get them the product. And even if it is simple CBD isolate or simple CBD product, we can still do it the best. And we feel like we have the best product to offer. Price wise, and quality certifications are a big thing. So, you know, we, we have a couple of people on our legal team that interact with FDA, and they've been very open with FDA to kind of help out with the structure when FDA finally puts some kind of regulation on how, and we are doing everything we can so that the company is in a place where when those regulations come out, we're above board, we're not catching up, we don't have to run and get a couple of different surgery ready to go. We're already there, and we're above it. And so they'll never be you know, any any issues with that a lot of companies that may have a cheaper price or, you know, lower mo Q's or something that might help try to get that that sale move forward. They might have those certifications, whether it's kosher, or organic, or cGMP certified, lots of things that are very important. If you're having especially an edible product, you need to know that that they are following these processes, right? You're not eating something or vaping something that's going to cause you harm, right. And that was a big issue with the vape industry with those street vendors, the vitamin E and everything else, right. I mean that that killed vape for everything for tobacco, everybody else because there were people and not and you would buy something without asking for certifications or anything to know where it's made, right? It's the same thing with any product, even skincare, you don't put something on that causes a rash hasn't been tested hasn't gone through, you know, certifications as you have something behind it to show, hey, this the product you bought, this is why, you know, we're we believe in it. And this company is built to do that. And there are other companies that have similar certifications, but none that have the robust certifications with the team with the interaction I think we can provide. And that's kind of you know, our leg forward on the market is the offering we have is very specific. And there's a lot of companies, I don't think there's any companies really to have that full portfolio that we have of cannabinoids, right. So instead of coming to one company that might be cheaper and getting a product with just CBD, but then tomorrow you want CBG CBN, you got to go another company, you come to us and we can do every different variation. Yeah, we can do different products for different issues that people are dealing with any you can stay with us. And we can have one rep working with you and kind of consulting with you on the way and helping you brand your business. And you know, that's what a lot of people want. They want stability, they want comfort, they want a friendly face that's going to do what's best for them and their company, because then we're both going to succeed together. Right. And I think you know, in this industry, especially that value is worth sometimes a little more, you know, cost and price and because the relationships there and they you know, they love to trust somebody. Yeah, right. They want to feel like they have something for the long run. They always have their back and be there to support them. Yeah.

Ronjini Joshua:

Do you think that the backward certificate thing is going to be a challenge when things kind of come to fruition. Like being going back and making sure you have all those certifications in place, like do you think that's going to be something that the industry is faced with? Because you know, it's not? We're kind of in progress. Yeah, it is.

Adam Bushey:

If you're not looking at similar industries that have similar capabilities, Sharon, so if you're if you look like skincare is great, if we're gonna make lotion at the facility, what are the facilities that are making lotion for Neutrogena and these other big companies? What are their requirements? What are their certifications, right? We have those as well, then we cover that aspect, right? If you look at an edible or a food company, what are their food regulations that they have, what things have they gone through, if we have those, then we're good on that side, he cover all those different industries that are similar to where we're going to be when FDA opens everything up, right, and we have all that set. And we do already. And we know, okay, we have cGMP, and food, we're there, we're set up to be Intraceuticals, we have all the different certifications for the separate industries. And it can't be more robust than those because those are already such a high echelon, right, and it's so hard to be certified in those for good reason. But I think that's where the tea is gonna be, it's gonna be combining all the different industries that are similar to cannabis. And if you're already there, then you're great. If not, and you're a little behind, you'll have time to get to catch

Ronjini Joshua:

up a little bit. But but then that's it, like there's no substitute for time. Like, as if you have if you have to take six months to 12 months to do that somebody else might edge you out of the market, like so that's it. That's a big deal.

Adam Bushey:

Yep. And fines and everything else you could deal with right? FTA and everything. And so we're looking forward to that very much, because I think it's gonna weed out a lot of the smaller companies that are causing harm, and with the vape and those kinds of things as well, right? It's gonna be nice to have everything regulated, everybody has to be held at the same bar. And, you know, to make the whole industry a lot cleaner and

Ronjini Joshua:

streamlined,

Ben Michaels:

maybe I'm curious. So what percentage would you say, you know, there's hundreds, that was 100, or hundreds of different cannabinoids, cannabinoids. And then what percentage do you think that you all figured out, you know, specifically to these different things? And then research wise, how many years up? Do you think we are to understanding all of them, if ever,

Adam Bushey:

I think that it's going to be expedited now because there's such a good focus on cannabis in general, everybody from the President to our grandmas are talking about, you know, him getting cannabis and everything else. Right. So that's helping because a lot of the colleges are getting involved. You know, before it was a lot of in Israel and Europe and other countries that were ahead of the game for it. And now we're finally catching up. We have a lot you know, more into hemp and CBD in general, as far as you know, studies and everything else. But as the cannabinoids become easier to isolate and easier to replicate, they're going to be able to do those studies based on those individual cannabinoids. And then at that point, we'll start having more studies done, we'll have more information about them. And I'm sure you know, over the next 50 years, we're going to be able to extract all the cannabinoids. But you know, for now, there's I think there's 10 that are really key right now. And they have all different aspects and purposes, for different products. And the real key is going to be finding a good solution to get a lot of information about those to have studies made to have, you know, panels done and have people kind of learn how these can actually affect the body, how they can help, Is there too much that somebody should not take is there's too little that won't do anything. There's so many different variables, right, that we have to go through, but run a good path now to single those out. And they've done a lot of work and CBG and CBN. Now, so those are kind of on the next level. And then we have all the next things coming and exciting things that you know, cbdv, CBDa, CBGa, THCV, there's so many exciting variable or exciting cannabinoids coming out that all needed to have go through that same process. So we can actually figure out okay, what does this for? What does it do? How do we make it make sure it's safe and all those kinds of things. So it's exciting. But you know, the more people talk about it, the more we have things like mjbizcon, we're great people come together and minds work. And, you know, the government takes notice, and they want to be a part of it. And they want to see how they get the tax money. Right. Yeah. So they're gonna support it and keep it growing. So, I mean, it's all it's all been good. The last 10 years have been huge, right. And I think the next time will be even better. Absolutely. I think within 10 years, we'll know a lot about these different cannabinoids and how to specifically target, you know, the need for each person.

Ronjini Joshua:

Yeah, this is awesome. I mean, that there's so much there's a lot of wealth of information when it comes to the plant like life and like the way you guys kind of inspect it and and research it because, you know, there's like, an endless pool of knowledge that you're tapping into. So it's really interesting to see, like, I feel like every month there's like some new letter coming out. So knowing what those things are going to do is going to be really cool.

Adam Bushey:

Yeah. You have a purpose. We just have to figure out what that is.

Ronjini Joshua:

Yeah, yeah. It'll be good. I'll check on your website today to see what's going on. Well, thank you so much for joining me, Adam. is where can people find you?

Adam Bushey:

Open Book extract. com. Find us on LinkedIn too. On Facebook, Instagram, but yeah, check out the website and lot information on there and then love to connect with everybody and talk more about it. So we're excited. All right. Thank you for having me. Yeah, absolutely.

Ronjini Joshua:

The Green Room podcast is brought to life by green seed PR, cannabis green tech focus PR agency, and a dedicated production team of editors mixers and show Booker's. A huge thank you to the vessel team for providing their studio for our recordings. Don't forget to subscribe and share the greenroom podcast with friends, colleagues and family. That way you'll never miss an episode and we can keep the lights on. If you're feeling extra generous, please leave us a review on your favorite podcast listening platform. You can also find us on Instagram at green seed PR and to the live video versions of all of our podcasts on YouTube. Would you like to be on the guest on the show or do you have a great guest referral? Awesome. Submit your guests at Green cpr.com/the-green-room Thanks for listening and be well